The group�s principle activity is to develop new technology and pioneering products to provide symptomatic relief for, and may help to slow the progression of chronic kidney failure. The group�s products include Kibow biotics(R) and metabolic syndrome products. The group operates from United States.
Executive Information
Name
Title
Email
Natarajan Ranganathan
Principal Founder, CEO, Sr. VP - Research & Development
